• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺激素抑制转化生长因子-β信号传导并减弱纤维化反应。

Thyroid hormones inhibit TGF-β signaling and attenuate fibrotic responses.

作者信息

Alonso-Merino Elvira, Martín Orozco Rosa, Ruíz-Llorente Lidia, Martínez-Iglesias Olaia A, Velasco-Martín Juan Pedro, Montero-Pedrazuela Ana, Fanjul-Rodríguez Luisa, Contreras-Jurado Constanza, Regadera Javier, Aranda Ana

机构信息

Instituto de Investigaciones Biomédicas "Alberto Sols," Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid, 20829 Madrid, Spain;

Departamento de Anatomía, Histología y Neurociencia, Facultad de Medicina, Universidad Autónoma de Madrid, 20829 Madrid, Spain.

出版信息

Proc Natl Acad Sci U S A. 2016 Jun 14;113(24):E3451-60. doi: 10.1073/pnas.1506113113. Epub 2016 May 31.

DOI:10.1073/pnas.1506113113
PMID:27247403
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4914168/
Abstract

TGF-β, the most potent profibrogenic factor, acts by activating SMAD (mothers against decapentaplegic) transcription factors, which bind to SMAD-binding elements in target genes. Here, we show that the thyroid hormone triiodothyronine (T3), through binding to its nuclear receptors (TRs), is able to antagonize transcriptional activation by TGF-β/SMAD. This antagonism involves reduced phosphorylation of SMADs and a direct interaction of the receptors with SMAD3 and SMAD4 that is independent of T3-mediated transcriptional activity but requires residues in the receptor DNA binding domain. T3 reduces occupancy of SMAD-binding elements in response to TGF-β, reducing histone acetylation and inhibiting transcription. In agreement with this transcriptional cross-talk, T3 is able to antagonize fibrotic processes in vivo. Liver fibrosis induced by carbon tetrachloride is attenuated by thyroid hormone administration to mice, whereas aged TR knockout mice spontaneously accumulate collagen. Furthermore, skin fibrosis induced by bleomycin administration is also reduced by the thyroid hormones. These findings define an important function of the thyroid hormone receptors and suggest TR ligands could have beneficial effects to block the progression of fibrotic diseases.

摘要

转化生长因子-β(TGF-β)是最有效的促纤维化因子,其作用机制是激活SMAD(果蝇抗五体不全蛋白)转录因子,这些转录因子与靶基因中的SMAD结合元件相结合。在此,我们表明,甲状腺激素三碘甲状腺原氨酸(T3)通过与其核受体(TRs)结合,能够拮抗TGF-β/SMAD介导的转录激活。这种拮抗作用涉及SMAD蛋白磷酸化减少,以及受体与SMAD3和SMAD4的直接相互作用,这种相互作用独立于T3介导的转录活性,但需要受体DNA结合域中的残基。T3可减少TGF-β诱导的SMAD结合元件的占据,减少组蛋白乙酰化并抑制转录。与这种转录相互作用一致,T3能够在体内拮抗纤维化过程。给小鼠注射甲状腺激素可减轻四氯化碳诱导的肝纤维化,而老年TR基因敲除小鼠会自发地积累胶原蛋白。此外,甲状腺激素也可减少博来霉素诱导的皮肤纤维化。这些发现确定了甲状腺激素受体的一项重要功能,并表明TR配体可能对阻止纤维化疾病的进展具有有益作用。

相似文献

1
Thyroid hormones inhibit TGF-β signaling and attenuate fibrotic responses.甲状腺激素抑制转化生长因子-β信号传导并减弱纤维化反应。
Proc Natl Acad Sci U S A. 2016 Jun 14;113(24):E3451-60. doi: 10.1073/pnas.1506113113. Epub 2016 May 31.
2
The expression dynamics of transforming growth factor-β/Smad signaling in the liver fibrosis experimentally caused by Clonorchis sinensis.华支睾吸虫所致实验性肝纤维化中转化生长因子-β/Smad信号通路的表达动态
Parasit Vectors. 2015 Feb 4;8:70. doi: 10.1186/s13071-015-0675-y.
3
Zinc finger protein 451 is a novel Smad corepressor in transforming growth factor-β signaling.锌指蛋白 451 是转化生长因子-β信号通路中的一种新型 Smad 核心抑制因子。
J Biol Chem. 2014 Jan 24;289(4):2072-83. doi: 10.1074/jbc.M113.526905. Epub 2013 Dec 9.
4
The novel PIAS-like protein hZimp10 enhances Smad transcriptional activity.新型PIAS样蛋白hZimp10增强Smad转录活性。
J Biol Chem. 2006 Aug 18;281(33):23748-56. doi: 10.1074/jbc.M508365200. Epub 2006 Jun 15.
5
Profibrogenic transforming growth factor-beta/activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes.通过肝细胞中结缔组织生长因子的表达,促纤维化转化生长因子-β/激活素受体样激酶5信号通路发挥作用。
Hepatology. 2007 Oct;46(4):1257-70. doi: 10.1002/hep.21806.
6
Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling.Smad7蛋白与受体调节型Smads(R-Smads)相互作用,以抑制转化生长因子-β(TGF-β)/Smad信号传导。
J Biol Chem. 2016 Jan 1;291(1):382-92. doi: 10.1074/jbc.M115.694281. Epub 2015 Nov 10.
7
Transforming growth factor-β (TGF-β) signaling in healthy human fetal skin: a descriptive study.健康人胎儿皮肤中的转化生长因子-β(TGF-β)信号传导:一项描述性研究。
J Dermatol Sci. 2015 May;78(2):117-24. doi: 10.1016/j.jdermsci.2015.02.012. Epub 2015 Feb 26.
8
Copy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver disease.外排蛋白 4 的拷贝数变异和表达与代谢相关脂肪性肝病肝纤维化严重程度相关。
EBioMedicine. 2021 Aug;70:103521. doi: 10.1016/j.ebiom.2021.103521. Epub 2021 Aug 11.
9
Transforming growth factor β inhibits bone morphogenetic protein-induced transcription through novel phosphorylated Smad1/5-Smad3 complexes.转化生长因子β通过新型磷酸化 Smad1/5-Smad3 复合物抑制骨形态发生蛋白诱导的转录。
Mol Cell Biol. 2012 Jul;32(14):2904-16. doi: 10.1128/MCB.00231-12. Epub 2012 May 21.
10
Regulation of fibronectin by thyroid hormone receptors.甲状腺激素受体对纤连蛋白的调节
J Mol Endocrinol. 2004 Oct;33(2):445-58. doi: 10.1677/jme.1.01505.

引用本文的文献

1
Thyroid hormone signaling in ocular development and diseases.甲状腺激素信号在眼部发育和疾病中的作用
Biol Res. 2025 Jul 2;58(1):42. doi: 10.1186/s40659-025-00618-1.
2
Association of Sensitivity to Thyroid Hormones and Non-Alcoholic Fatty Liver Disease and the Severity of Liver Fibrosis in Euthyroid Adults: A Retrospective Study.甲状腺激素敏感性与正常甲状腺功能成年人非酒精性脂肪性肝病及肝纤维化严重程度的相关性:一项回顾性研究。
Diabetes Metab Syndr Obes. 2025 Feb 17;18:479-490. doi: 10.2147/DMSO.S499517. eCollection 2025.
3
Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment.代谢功能障碍相关脂肪性肝病:一种具有异质性代谢风险因素、机制和合并症且需要整体治疗的疾病。
Nat Rev Gastroenterol Hepatol. 2025 May;22(5):314-328. doi: 10.1038/s41575-025-01045-z. Epub 2025 Feb 17.
4
Advances and challenges in kidney fibrosis therapeutics.肾纤维化治疗的进展与挑战
Nat Rev Nephrol. 2025 May;21(5):314-329. doi: 10.1038/s41581-025-00934-5. Epub 2025 Feb 11.
5
Diverting hepatic lipid fluxes with lifestyles revision and pharmacological interventions as a strategy to tackle steatotic liver disease (SLD) and hepatocellular carcinoma (HCC).通过改变生活方式和药物干预来改变肝脏脂质通量,以此作为应对脂肪性肝病(SLD)和肝细胞癌(HCC)的一种策略。
Nutr Metab (Lond). 2024 Dec 23;21(1):112. doi: 10.1186/s12986-024-00871-3.
6
Correlation Between Thyroid Hormone and Controlled Attenuation Parameters: A Cross-Sectional Population-Based Study.甲状腺激素与受控衰减参数之间的相关性:一项基于人群的横断面研究。
Diabetes Metab Syndr Obes. 2024 Dec 15;17:4777-4787. doi: 10.2147/DMSO.S490347. eCollection 2024.
7
Triiodothyronine Is Associated with Incidence/Resolution of Steatotic Liver Disease: Longitudinal Study in Euthyroid Korean.三碘甲状腺原氨酸与脂肪性肝病的发生/转归相关:甲状腺功能正常的韩国人的纵向研究
Endocrinol Metab (Seoul). 2025 Feb;40(1):135-145. doi: 10.3803/EnM.2024.2040. Epub 2024 Dec 4.
8
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH).代谢功能障碍相关脂肪性肝炎(MASH)的治疗前景
Nat Rev Drug Discov. 2025 Mar;24(3):171-189. doi: 10.1038/s41573-024-01084-2. Epub 2024 Nov 28.
9
Thyroid Hormone Action by Genomic and Nongenomic Molecular Mechanisms.甲状腺激素的基因组和非基因组分子机制作用。
Methods Mol Biol. 2025;2876:17-34. doi: 10.1007/978-1-0716-4252-8_2.
10
Potential therapeutic impacts of vitamin D on hypothyroid-induced heart and kidney fibrosis and oxidative status in male rat.维生素D对雄性大鼠甲状腺功能减退所致心脏和肾脏纤维化及氧化状态的潜在治疗作用
Naunyn Schmiedebergs Arch Pharmacol. 2025 May;398(5):5237-5248. doi: 10.1007/s00210-024-03593-8. Epub 2024 Nov 13.

本文引用的文献

1
Thyroid hormone regulation of hepatic lipid and carbohydrate metabolism.甲状腺激素对肝脏脂质和碳水化合物代谢的调节。
Trends Endocrinol Metab. 2014 Oct;25(10):538-45. doi: 10.1016/j.tem.2014.07.001. Epub 2014 Aug 12.
2
Thyroid hormone regulation of metabolism.甲状腺激素对代谢的调节。
Physiol Rev. 2014 Apr;94(2):355-82. doi: 10.1152/physrev.00030.2013.
3
Liver fibrosis and repair: immune regulation of wound healing in a solid organ.肝纤维化与修复:实体器官中创伤愈合的免疫调控。
Nat Rev Immunol. 2014 Mar;14(3):181-94. doi: 10.1038/nri3623.
4
The thyroid hormone receptor β induces DNA damage and premature senescence.甲状腺激素受体 β 诱导 DNA 损伤和过早衰老。
J Cell Biol. 2014 Jan 6;204(1):129-46. doi: 10.1083/jcb.201305084.
5
Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis.丙硫氧嘧啶可预防活性氧物种诱导的系统性硬化症小鼠模型的皮肤和肺纤维化。
Arthritis Res Ther. 2013 Sep 16;15(5):R120. doi: 10.1186/ar4300.
6
A nonclassical vitamin D receptor pathway suppresses renal fibrosis.一种非经典维生素 D 受体途径抑制肾纤维化。
J Clin Invest. 2013 Nov;123(11):4579-94. doi: 10.1172/JCI67804. Epub 2013 Oct 25.
7
Receptors of thyroid hormones.甲状腺激素的受体
Pediatr Endocrinol Rev. 2013 Sep;11(1):2-13.
8
Both hypothyroidism and hyperthyroidism increase atrial fibrillation inducibility in rats.甲状腺功能减退症和甲状腺功能亢进症均可增加大鼠心房颤动的易感性。
Circ Arrhythm Electrophysiol. 2013 Oct;6(5):952-9. doi: 10.1161/CIRCEP.113.000502. Epub 2013 Sep 14.
9
A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response.维生素 D 受体/SMAD 基因组回路调控肝纤维化反应。
Cell. 2013 Apr 25;153(3):601-13. doi: 10.1016/j.cell.2013.03.028.
10
TGFβ signalling in context.TGFβ 信号通路在语境中的作用。
Nat Rev Mol Cell Biol. 2012 Oct;13(10):616-30. doi: 10.1038/nrm3434. Epub 2012 Sep 20.